Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Melphalan
Plasma Cell Leukemia
National Cancer Institute (NCI)
P2
BBB
(72)
Melphalan
B-Cell Chronic Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
P2
BBB
(72)
Mesna
Acute Lymphoblastic Leukemia
Center for International Blood and Marrow Transplant Research
P2
BBB
(72)
Nivolumab
Castration-Resistant Prostate Carcinoma
Rana McKay, MD
P2
BBB
(72)
Nivolumab
Colorectal Adenocarcinoma
University Hospital, Akershus
P2
BBB
(72)
Nivolumab
Colorectal Carcinoma
Fred Hutchinson Cancer Center
P2
BBB
(72)
Nivolumab
Lymphoma
National Cancer Institute (NCI)
P2
BBB
(72)
Nivolumab
Peripheral T-Cell Lymphoma, Not Otherwise Specified
University of Michigan Rogel Cancer Center
P2
BBB
(72)
Oxaliplatin
B-Cell Non-Hodgkin Lymphoma
Mwanasha Merrill, MD
P2
BBB
(72)
Pembrolizumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Roswell Park Cancer Institute
P2
BBB
(72)
Pembrolizumab
Estrogen-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BBB
(72)
Pembrolizumab
Marginal Zone Lymphoma
University of Ulm
P2
BBB
(72)
Pembrolizumab
Mycosis Fungoides
Sorrento Therapeutics, Inc.
P2
BBB
(72)
Pembrolizumab
Pancreatic Adenocarcinoma
Mayo Clinic
P2
BBB
(72)
Pembrolizumab
Progesterone-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BBB
(72)
Pembrolizumab
Metastatic Prostate Carcinoma
CuraCell TX AB
P2
BBB
(72)
Pembrolizumab
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Mayo Clinic
P2
BBB
(72)
Pembrolizumab
Sarcoma
Essen Biotech
P2
BBB
(72)
Poly-Iclc
Melanoma
Washington University School of Medicine
P2
BBB
(72)
Sirolimus
Hematopoietic And Lymphoid System Neoplasm
Stanford University
P2
BBB
(72)
Tacrolimus
Leukemia, Myeloid, Accelerated-Phase
University of Michigan Rogel Cancer Center
P2
BBB
(72)
Tacrolimus
Adult Acute Lymphoblastic Leukemia
Sumithira Vasu
P2
BBB
(72)
Tacrolimus
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P2
BBB
(72)
Tacrolimus
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesota
P2
BBB
(72)
Tacrolimus
Lymphoblastic Lymphoma
St. Petersburg State Pavlov Medical University
P2
BBB
(72)
Showing 2201 to 2225 of 42,286 assets
Previous
Page 89 of 1692
Next